Chemodex

Trazodone hydrochloride

As low as CHF 45.00
In stock
Only %1 left
CDX-T0476-G0011 gCHF 45.00
CDX-T0476-G0055 gCHF 103.00
 

Specifications / Handling

More Information
Product Details
Synonyms 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one hydrochloride; AF 1161; Desyrel; Molipaxin; KB 831; Pragmazone; Thombran; Trazolan; Tombran; Trittico; Bimaran; Mesyrel
Product Type Chemical
Properties
Formula C19H22ClN5O . HCl
MW 408.32
CAS 25332-39-2
RTECS XZ5660000
Source/Host Chemicals Synthetic
Purity Chemicals ≥99% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in DMSO (10mg/ml), methanol (10mg/ml) or water (1mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key OHHDIOKRWWOXMT-UHFFFAOYSA-N
Smiles ClC1=CC=CC(N(CC2)CCN2CCCN3N=C(C=CC=C4)N4C3=O)=C1.Cl
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF Download PDF

Scientific Background Information

Product Description
Trazodone hydrochloride belongs to the class of serotonin receptor antagonists and reuptake inhibitors (SARIs). Trazodone hydrochloride has anti-depressant and neuroprotectant activity. Trazodone hydrochloride exerts antagonistic properties against α1- and α2-adrenergic receptors and histamine H1 receptors, with minimal anticholinergic effects. Shown to enhance neuronal differentiation of mouse and human neural progenitor cells. Also inhibits PERK/eIF2α-P-mediated reduction in protein synthesis and restores memory deficits in a mouse dementia model. Its broad pharmacological activity makes it a valuable tool in both neuroscience research and therapeutic development. Can be used as a reference compound.
Product-specific References
(1) A. Georgotas, et al.; Pharmacotherapy 2, 255 (1982) | (2) S.G. Bryant & L. Ereshefsky; Clin. Pharm. 1, 406 (1982) | (3) A. Fagiolini, et al.; Review CNS Drugs 26, 1033 (2012) | (4) M. Halliday, et al.; Brain 140, 1768 (2017) | (5) V. Bortolotto, et al.; ACS Chem. Neurosci. 8, 2027 (2017)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.